Multiomic biomarkers after cardiac arrest
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Predicting neurological outcomes after cardiac arrest remains challenging. Multiomic signatures, analyzed with AI, show promise for improving prognostic accuracy and patient care.
Area Of Science
- Biomedical research
- Cardiology
- Genomics and Proteomics
Background
- Cardiac arrest is a critical medical emergency with high mortality.
- Accurate prediction of neurological outcomes post-cardiac arrest is crucial for patient management.
- Current prognostic methods lack sufficient accuracy, hindering personalized treatment strategies.
Purpose Of The Study
- To review existing omic biomarkers for predicting cardiac arrest outcomes.
- To explore the potential of multiomic signatures in improving prognostic accuracy.
- To identify future research directions for integrating multiomic data in cardiac arrest care.
Main Methods
- Comprehensive literature review of omic biomarkers.
- Analysis of emerging technologies for multi-omics data integration.
- Exploration of artificial intelligence and machine learning applications.
Main Results
- Various omic fields offer potential biomarkers for cardiac arrest prognosis.
- Multi-omics data integration presents a promising avenue for enhanced prediction.
- AI and machine learning can facilitate the analysis of complex multiomic datasets.
Conclusions
- Integrating multiomic data holds significant potential for improving cardiac arrest outcome prediction.
- Future research should focus on developing and validating multiomic signatures.
- Advancements in this area can lead to more personalized and effective patient care.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...